Alvimopan

Drug Details

Alvimopan, marketed under the brand name Entereg, is an opioid antagonist designed to aid adults in recovering more swiftly from intestinal surgery. Its primary function is to counteract the bowel-slowing effects of opioid pain medications, which are often prescribed post-surgery. By doing so, Alvimopan helps to restore normal bowel function, thereby reducing recovery time and minimizing the risk of complications such as intestinal blockages. The medication is typically administered by taking the first dose just before surgery, followed by twice-daily doses for up to a week while the patient remains in the hospital. A common side effect associated with Alvimopan is indigestion. Always consult with your healthcare provider for personalized medical advice before using this medication.